Matthew Mendel

1.7k total citations
13 papers, 684 citations indexed

About

Matthew Mendel is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Matthew Mendel has authored 13 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Oncology. Recurrent topics in Matthew Mendel's work include CRISPR and Genetic Engineering (6 papers), Virus-based gene therapy research (3 papers) and CAR-T cell therapy research (3 papers). Matthew Mendel is often cited by papers focused on CRISPR and Genetic Engineering (6 papers), Virus-based gene therapy research (3 papers) and CAR-T cell therapy research (3 papers). Matthew Mendel collaborates with scholars based in United States, Austria and Russia. Matthew Mendel's co-authors include Michael C. Holmes, Jeffrey C. Miller, Danny F. Xia, Jianbin Wang, Fyodor D. Urnov, Yannick Doyon, Thuy D. Vo, Philip D. Gregory, Peiqi Liu and Casey C. Case and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Nature Methods.

In The Last Decade

Matthew Mendel

13 papers receiving 665 citations

Peers

Matthew Mendel
Comparison fields: 5 of 62
  • Molecular Biology 609
  • Genetics 169
  • Plant Science 71
  • Pulmonary and Respiratory Medicine 43
  • Oncology 39
Stamatis Papathanasiou United States
Julian Boutin France
Aline Marnef France
King L. Hung United States
Sivaprakash Ramalingam India
Giulia Maule Italy
Rene H. Quintanilla United States
Lior Nissim Israel
Cameron Arakaki United States
Stamatis Papathanasiou United States View profile →
Citations per field, relative to Matthew Mendel
Matthew Mendel · 1×
Citations per year, relative to Matthew Mendel
Matthew Mendel · 1×

Countries citing papers authored by Matthew Mendel

Since Specialization
Citations

This map shows the geographic impact of Matthew Mendel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Mendel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Mendel more than expected).

Fields of papers citing papers by Matthew Mendel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Mendel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Mendel. The network helps show where Matthew Mendel may publish in the future.

Co-authorship network of co-authors of Matthew Mendel

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Mendel. A scholar is included among the top collaborators of Matthew Mendel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Mendel. Matthew Mendel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
# Title Journal Authors Indexed citations
1 A serum- and feeder-free system to generate CD4 and regulatory T cells from human iPSCs Stem Cells Helen Fong, Matthew Mendel et al. 3
2 Resolution of hepatic fibrosis after ZFN-mediated gene editing in the PiZ mouse model of human α1-antitrypsin deficiency Hepatology Communications Yanfeng Li, Chandan Guha et al. 5
3 Highly Efficient Gene Editing of Cystic Fibrosis Patient-Derived Airway Basal Cells Results in Functional CFTR Correction Molecular Therapy Shingo Suzuki, Ana M. Crane et al. 60
4 Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets Molecular Therapy Anthony Conway, Matthew Mendel et al. 69
5 Delivery of Genome Editing Reagents to Hematopoietic Stem/Progenitor Cells Current Protocols in Stem Cell Biology Megan D. Hoban, Zulema Romero et al. 9
6 Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures Nature Methods Yannick Doyon, Thuy D. Vo et al. 306
7 Targeted Killing of Glioblastoma Multiforme In Vivo by IL-13 Zetakine Redirected CTLs Made Glucocorticoid Resistant with Zinc Finger Nucleases. Blood Andreas Reik, Michael C. Holmes et al. 1
8 Pharmacological analysis of CCK2 receptors up-regulated using engineered transcription factors Regulatory Peptides Magda F. Morton, Peiqi Liu et al. 6
9 Isogenic Human Cell Lines for Drug Discovery: Regulation of Target Gene Expression by Engineered Zinc-Finger Protein Transcription Factors SLAS DISCOVERY Peiqi Liu, Siyuan Tan et al. 11
10 Cell Lines for Drug Discovery: Elevating Target-Protein Levels Using Engineered Transcription Factors SLAS DISCOVERY Peiqi Liu, Magda F. Morton et al. 8
11 The Last Gene of the fla/che Operon in Bacillus subtilis , ylxL , Is Required for Maximal σ D Function Journal of Bacteriology Paloma López, Matthew Mendel et al. 14
12 Regulation of an Endogenous Locus Using a Panel of Designed Zinc Finger Proteins Targeted to Accessible Chromatin Regions Journal of Biological Chemistry Peiqi Liu, Edward J. Rebar et al. 191
13 Chronic lower back pain due to sarcoma. PubMed Wolfgang Hueber, Martin Dominkus et al. 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026